These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 12406662)

  • 1. What's in the pipeline? Prospects for monoclonal antibodies (mAbs) as therapies for lung diseases.
    Li L; Das AM; Torphy TJ; Griswold DE
    Pulm Pharmacol Ther; 2002; 15(5):409-16. PubMed ID: 12406662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoclonal antibodies for asthma and chronic obstructive pulmonary disease.
    Antoniu SA
    Expert Opin Biol Ther; 2013 Feb; 13(2):257-68. PubMed ID: 23282002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal antibodies as a strategy for pulmonary diseases.
    Torphy TJ; Li L; Griswold DE
    Curr Opin Pharmacol; 2001 Jun; 1(3):265-71. PubMed ID: 11712750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Agents against cytokine synthesis or receptors.
    Yamagata T; Ichinose M
    Eur J Pharmacol; 2006 Mar; 533(1-3):289-301. PubMed ID: 16457805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoclonal antibody therapy for the treatment of asthma and chronic obstructive pulmonary disease with eosinophilic inflammation.
    Nixon J; Newbold P; Mustelin T; Anderson GP; Kolbeck R
    Pharmacol Ther; 2017 Jan; 169():57-77. PubMed ID: 27773786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of transcription factors in the pathogenesis of asthma and COPD.
    Caramori G; Casolari P; Adcock I
    Cell Commun Adhes; 2013 Feb; 20(1-2):21-40. PubMed ID: 23472830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting immune pathways for therapy in asthma and chronic obstructive pulmonary disease.
    Brusselle G; Bracke K
    Ann Am Thorac Soc; 2014 Dec; 11 Suppl 5():S322-8. PubMed ID: 25525740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of cigarette smoke on airway inflammation in asthma and COPD: therapeutic implications.
    Tamimi A; Serdarevic D; Hanania NA
    Respir Med; 2012 Mar; 106(3):319-28. PubMed ID: 22196881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunology of asthma and chronic obstructive pulmonary disease.
    Barnes PJ
    Nat Rev Immunol; 2008 Mar; 8(3):183-92. PubMed ID: 18274560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of inflammatory cell function by corticosteroids.
    Belvisi MG
    Proc Am Thorac Soc; 2004; 1(3):207-14. PubMed ID: 16113436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small molecule inhibitors of cell signaling: novel future therapeutics for asthma and chronic obstructive pulmonary diseases.
    Blease K; Raymon HK
    Curr Opin Investig Drugs; 2003 May; 4(5):544-51. PubMed ID: 12833647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Engineering approaches to develop the next generation of antibodies to respiratory targets.
    Vousden KA; Clarke DL; Lowe DC
    Inflamm Allergy Drug Targets; 2013 Apr; 12(2):99-108. PubMed ID: 23517646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoclonal antibodies for the treatment of asthma.
    Catley MC; Coote J; Bari M; Tomlinson KL
    Pharmacol Ther; 2011 Dec; 132(3):333-51. PubMed ID: 21944943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Role of monoclonal anti-IgE antibodies (rhu-MAb) in the treatment of allergic bronchial asthma].
    Targowski T; From S
    Pol Merkur Lekarski; 2003 Jan; 14(79):65-8. PubMed ID: 12712834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting 5-lipoxygenase-activating protein in asthma and chronic obstructive pulmonary disease.
    Antoniu SA
    Expert Opin Ther Targets; 2014 Nov; 18(11):1285-92. PubMed ID: 25213852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biologic therapies for chronic obstructive pulmonary disease.
    Matera MG; Calzetta L; Cazzola M; Ora J; Rogliani P
    Expert Opin Biol Ther; 2023 Feb; 23(2):163-173. PubMed ID: 36527286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Handle with care: targeting neutrophils in chronic obstructive pulmonary disease and severe asthma?
    Beeh KM; Beier J
    Clin Exp Allergy; 2006 Feb; 36(2):142-57. PubMed ID: 16433851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-immunoglobulin E treatment with omalizumab in allergic diseases: an update on anti-inflammatory activity and clinical efficacy.
    Holgate ST; Djukanović R; Casale T; Bousquet J
    Clin Exp Allergy; 2005 Apr; 35(4):408-16. PubMed ID: 15836747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic Monoclonal Antibodies for the Treatment of Chronic Obstructive Pulmonary Disease.
    Matera MG; Page C; Rogliani P; Calzetta L; Cazzola M
    Drugs; 2016 Sep; 76(13):1257-1270. PubMed ID: 27506851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of omalizumab on IgE-induced cytokine synthesis by asthmatic airway smooth muscle cells.
    Roth M; Tamm M
    Ann Allergy Asthma Immunol; 2010 Feb; 104(2):152-60. PubMed ID: 20306819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.